Sanofi – Aventis Pakistan ltd. profit for 9MFY17 rises 56.16% to Rs. 974 million

  • Sanofi – Aventis Pakistan ltd. sales – net  for the period increased by 3.38%, amounting to a total of 9.76 billion Rupees during the nine months ended September, 30th 2017
  • Company’s Gross Profit for the period increased by 14% 3.6 bilion
  • Company’s Administrative Expenses and Other operation costs increased by 31.22% and 131.45% respectively
  • The Profit after tax for the period increased 56.16% reaching 974 million against last year’s nine months profits of Rs. 606 million
  • The company’s basic earnings per share reached rupees 98.22 against 62.90 rupees in 2016
Comparison of Key Financials

Unconsolidated Profit and Loss Account – For the Nine Months Ended, September 30th 2017

Key Financials

2017

2016

% Change

 

Amounts in PKR ‘000

Net Sales

9,767,953

9,448,593

3.38%

Cost of Sales

6,123,933

6,256,813

-2.12%

Gross Profit

3,644,020

3,191,780

14.17%

Dist: and Marketing Expenses

1,613,300

1,603,527

0.61%

Administrative Expenses

294,998

224,807

31.22%

Other operating expenses

348,888

150,739

131.45%

Other operating income

35,858

27,331

31.20%

Operating Profit

1,422,692

1,240,038

14.73%

Finance costs

29,405

131,394

-77.62%

Profit before Taxation

1,393,287

1,108,644

25.67%

Taxation

445,987

502,005

-11.16%

Net profit for the period

947,300

606,639

56.16%

Basic and diluted – EPS

98.22

62.90

56.15%

Company release on Earnings Report can be accessed here.

Posted on: 2017-10-27T11:13:00+05:00